These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37967775)

  • 1. Astragalus polysaccharide attenuates nonalcoholic fatty liver disease through THDCA in high-fat diet-fed mice.
    Zheng N; Wang H; Zhu W; Li Y; Li H
    J Ethnopharmacol; 2024 Feb; 320():117401. PubMed ID: 37967775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desulfovibrio vulgaris, a potent acetic acid-producing bacterium, attenuates nonalcoholic fatty liver disease in mice.
    Hong Y; Sheng L; Zhong J; Tao X; Zhu W; Ma J; Yan J; Zhao A; Zheng X; Wu G; Li B; Han B; Ding K; Zheng N; Jia W; Li H
    Gut Microbes; 2021; 13(1):1-20. PubMed ID: 34125646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaempferol attenuates nonalcoholic steatohepatitis by regulating serum and liver bile acid metabolism.
    Lu Y; Shao M; Zhang C; Xiang H; Wang J; Wu T; Ji G
    Front Pharmacol; 2022; 13():946360. PubMed ID: 36249786
    [No Abstract]   [Full Text] [Related]  

  • 4. Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism.
    Wang S; Sheng F; Zou L; Xiao J; Li P
    J Adv Res; 2021 Dec; 34():109-122. PubMed ID: 35024184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in bile acids after sleeve gastrectomy improves metabolism by activating GPBAR1 to increase cAMP in mice with nonalcoholic fatty liver disease.
    Li G; Xu X; Chai L; Guo Q; Wu W
    Immun Inflamm Dis; 2024 Jul; 12(7):e1149. PubMed ID: 39031498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice.
    Li X; Zhao W; Xiao M; Yu L; Chen Q; Hu X; Zhao Y; Xiong L; Chen X; Wang X; Ba Y; Guo Q; Wu X
    J Ethnopharmacol; 2022 Aug; 294():115333. PubMed ID: 35500802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soyasaponin A
    Xiong F; Zheng Z; Xiao L; Su C; Chen J; Gu X; Tang J; Zhao Y; Luo H; Zha L
    Mol Nutr Food Res; 2021 Jul; 65(14):e2100067. PubMed ID: 34047448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stigmasterol Protects Against Steatohepatitis Induced by High-Fat and High-Cholesterol Diet in Mice by Enhancing the Alternative Bile Acid Synthesis Pathway.
    Xin Y; Li X; Zhu X; Lin X; Luo M; Xiao Y; Ruan Y; Guo H
    J Nutr; 2023 Jul; 153(7):1903-1914. PubMed ID: 37269906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota.
    Chen L-p; Zhang L-f; Liu S; Hua H; Zhang L; Liu B-c; Wang R-r
    Microbiol Spectr; 2024 Jun; 12(6):e0197923. PubMed ID: 38647315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bile acids contribute to the development of non-alcoholic steatohepatitis in mice.
    Gillard J; Clerbaux LA; Nachit M; Sempoux C; Staels B; Bindels LB; Tailleux A; Leclercq IA
    JHEP Rep; 2022 Jan; 4(1):100387. PubMed ID: 34825156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Turnover of bile acids in liver, serum and caecal content by high-fat diet feeding affects hepatic steatosis in rats.
    Tang Y; Zhang J; Li J; Lei X; Xu D; Wang Y; Li C; Li X; Mao Y
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Oct; 1864(10):1293-1304. PubMed ID: 31170503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gracilaria chorda subcritical water ameliorates hepatic lipid accumulation and regulates glucose homeostasis in a hepatic steatosis cell model and obese C57BL/6J mice.
    Thakuri LS; Park CM; Kim HA; Kim HJ; Park JW; Park JC; Rhyu DY
    J Ethnopharmacol; 2024 Feb; 320():117395. PubMed ID: 37952731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaloids of dendrobium nobile lindl. Altered hepatic lipid homeostasis via regulation of bile acids.
    Huang S; Wu Q; Liu H; Ling H; He Y; Wang C; Wang Z; Lu Y; Lu Y
    J Ethnopharmacol; 2019 Sep; 241():111976. PubMed ID: 31132462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
    Chen M; Guo WL; Li QY; Xu JX; Cao YJ; Liu B; Yu XD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Apr; 11(4):3316-3331. PubMed ID: 32226996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-hepatic steatosis activity of Sicyos angulatus extract in high-fat diet-fed mice and chemical profiling study using UHPLC-qTOF-MS/MS spectrometry.
    An JP; Choi JH; Huh J; Lee HJ; Han S; Noh JR; Kim YH; Lee CH; Oh WK
    Phytomedicine; 2019 Oct; 63():152999. PubMed ID: 31280138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new mechanism of thyroid hormone receptor β agonists ameliorating nonalcoholic steatohepatitis by inhibiting intestinal lipid absorption via remodeling bile acid profiles.
    Sun K; Zhu NL; Huang SL; Qu H; Gu YP; Qin L; Liu J; Leng Y
    Acta Pharmacol Sin; 2024 Oct; 45(10):2134-2148. PubMed ID: 38789494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoastragaloside I attenuates cholestatic liver diseases by ameliorating liver injury, regulating bile acid metabolism and restoring intestinal barrier.
    Zhang L; Jiang X; Shi J; Zhang J; Shi X; Xie Z; Chen G; Zhang H; Mu Y; Chen J; Qi S; Liu P; Liu W
    J Ethnopharmacol; 2024 Dec; 335():118649. PubMed ID: 39094754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1.
    Shang Z; Gao Y; Xue Y; Zhang C; Qiu J; Qian Y; Fang M; Zhang X; Sun X; Kong X; Gao Y
    Phytomedicine; 2024 Jan; 123():155183. PubMed ID: 37992491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.